MoonLake Immunotherapeutics MLTX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's investment purchases?
- MoonLake Immunotherapeutics (MLTX) reported investment purchases of $59.07M in Q1 2026.
- How has MoonLake Immunotherapeutics's investment purchases changed year-over-year?
- MoonLake Immunotherapeutics's investment purchases decreased by 33.3% year-over-year, from $88.55M to $59.07M.
- What is the long-term trend for MoonLake Immunotherapeutics's investment purchases?
- Over 3 years (2022 to 2025), MoonLake Immunotherapeutics's investment purchases has grown at a 84.5% compound annual growth rate (CAGR), from $42.23M to $265.37M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.